CCA
GEHC icon

Catalyst Capital Advisors’s GE HealthCare GEHC Stock Holding History

Catalyst Capital Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Buy
220
+69
+46% +$4.54K ﹤0.01% 347
2026
Q1 		$10.7K Sell
151
-20
-12% -$1.58K ﹤0.01% 363
2025
Q4 		$14K Sell
171
-62
-27% -$4.83K ﹤0.01% 376
2025
Q3 		$17.5K Sell
233
-45
-16% -$3.36K ﹤0.01% 430
2025
Q2 		$20.6K Sell
278
-74
-21% -$5.15K ﹤0.01% 439
2025
Q1 		$28.4K Sell
352
-3
-0.8% -$258 ﹤0.01% 399
2024
Q4 		$27.8K Hold
355
– – ﹤0.01% 415
2024
Q3 		$33.3K Sell
355
-84
-19% -$7.05K ﹤0.01% 381
2024
Q2 		$34.2K Buy
439
+15
+4% +$1.22K ﹤0.01% 277
2024
Q1 		$38.5K Sell
424
-3
-0.7% -$250 ﹤0.01% 265
2023
Q4 		$33K Buy
427
+91
+27% +$6.37K ﹤0.01% 255
2023
Q3 		$22.9K Buy
336
+85
+34% +$6.18K ﹤0.01% 320
2023
Q2 		$20.4K Buy
+251
New +$20K ﹤0.01% 312

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Catalyst Capital Advisors's GEHC Position: Q2 2026 in Review

Catalyst Capital Advisors increased its GE HealthCare (GEHC) stake by 46% in Q2 2026, buying an estimated $4.54K and bringing the position to 220 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Catalyst Capital Advisors first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $38.5K in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Catalyst Capital Advisors held 220 shares of GE HealthCare worth $14.1K as of Q2 2026.
  • Catalyst Capital Advisors bought 69 GE HealthCare shares in Q2 2026, an estimated $4.54K.
  • GE HealthCare made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #347 holding.
  • Catalyst Capital Advisors first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Catalyst Capital Advisors's GE HealthCare position peaked at $38.5K in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.